UPDATE
: Thursday, December 12, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GC Labcell releases trial results of NK-cell combination treatment
by Lee Han-soo
2019-12-12 18:00
Eli Lilly Korea launches migraine prevention drug
by Lee Han-soo
2019-12-12 15:28
Sanofi releases new meta-analysis data for diabetes treatment Soliqua
by Lee Han-soo
2019-12-12 15:01
Hanmi unveils new data at American Society of Hematology
by Lee Han-soo
2019-12-12 14:17
Bayer Korea names Freda Lin as new president
by Lee Han-soo
2019-12-12 14:16
라인
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
by Lee Han-soo
2019-12-11 15:30
ABL Bio unveils new bispecific antibody at US meet
by Lee Han-soo
2019-12-10 18:12
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
by Lee Han-soo
2019-12-10 11:43
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
by Lee Han-soo
2019-12-10 11:43
AbbVie's releases new data for chronic lymphocytic leukemia treatment
by Lee Han-soo
2019-12-09 17:42
라인
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
by Lee Han-soo
2019-12-09 16:15
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
by Kim Yun-mi
2019-12-09 14:39
New MSD labor union launched with fresh resolve
by Jeong Sae-im
2019-12-09 14:37
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
by Lee Han-soo
2019-12-06 17:06
AbbVie’s Venclexta nears insurance benefit
by Kim Eun-young
2019-12-06 16:35
라인
Syntekabio, CHA Hospital to co-develop immunotherapy
by Lee Han-soo
2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs
by Lee Han-soo
2019-12-06 15:03
Petitioner demands broader benefit for ovarian cancer drug Zejula
by Song Soo-youn
2019-12-06 15:02
China OKs Humedix's hyaluronic acid filler
by Lee Han-soo
2019-12-06 15:02
‘Lynparza raises value of precision medicine as anticancer treatment’
by Kim Yun-mi
2019-12-05 16:05
-
1
2
3
4
5
6
7
8
9
10
다음
-
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
GC Labcell releases trial results of NK-cell combination treatment
Laparoscopic surgery effective in treating cancer in pancreas head
Eli Lilly Korea launches migraine prevention drug
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
여백
Most viewed
1
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
2
Syntekabio, CHA Hospital to co-develop immunotherapy
3
‘Endogenous T cells have high potential of treating blood, solid tumors’
4
AbbVie’s Venclexta nears insurance benefit
5
Aprogen, 1st Korean biotech firm to win unicorn status
6
AMC unravels clues in treating relapsing, metastatic bladder cancer
7
Korea selected as 'Medical Tourism Destination of the Year'
8
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
9
AbbVie's releases new data for chronic lymphocytic leukemia treatment
10
ABL Bio unveils new bispecific antibody at US meet
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top